Lindsay Killingsworth
Obstetrics & Gynecology · Cumming, GANPI 1548478191
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,724 of the $3,824 with a category attached, or 71.2%. 33 manufacturers reported payments, led by IBSA Pharma Inc. at 27.2% of the total. Reporting peaked in 2023 at $1,490 and has fallen 73.0% since, to $403 in 2025.
Across 150 payments — averaging $25.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- IBSA Pharma Inc.$1K
- AbbVie$647
- Mayne Pharma Commercial LLC$197
- Exeltis, USA Inc.$179
- Evofem Biosciences, Inc.$161
- Lupin Inc.$141
- plus $1K from 27 others
What the payments were for
- Consulting fees$1,00026%
- Food & beverage$2,72471%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| IBSA Pharma Inc. | 3 | $1,039 |
| AbbVie(2 entities) | 31 | $647 |
| Mayne Pharma Commercial LLC | 13 | $197 |
| Exeltis, USA Inc. | 10 | $179 |
| Evofem Biosciences, Inc. | 11 | $161 |
| Lupin Inc. | 8 | $141 |
| Astellas Pharma US Inc | 3 | $140 |
| Bayer | 9 | $128 |
| Sumitomo Pharma America, Inc. | 6 | $103 |
| Baxter Healthcare | 5 | $101 |
| Daiichi Sankyo Inc. | 4 | $83 |
| Biogen | 3 | $83 |
| Myovant Sciences Inc. | 5 | $80 |
| Organon | 4 | $69 |
| Novo Nordisk | 4 | $68 |
| Agile Therapeutics, Inc. | 3 | $61 |
| Channel Medsystems, Inc. | 1 | $52 |
| Dexcom, Inc. | 2 | $51 |
| Duchesnay USA Incorporated | 2 | $49 |
| Optumhealth Care Solutions, LLC | 2 | $47 |
| Pfizer | 3 | $45 |
| Medtronic | 1 | $44 |
| Avion Pharmaceuticals | 3 | $35 |
| Exact Sciences | 2 | $32 |
| Cumberland Pharmaceuticals, Inc. | 2 | $31 |
| Mylan Pharmaceuticals Inc. | 2 | $29 |
| Coopersurgical, Inc. | 2 | $27 |
| Medline Industries LP | 1 | $25 |
| Millicent US Inc | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Covidien LP | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tirosint$1,000
How this compares
$3,824 in reported general payments places this provider in the 85th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 12 | $229 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cumming
- Julie FrymanCumming$9K
- Edmund KimLawrenceville$628K
- Jacquelin WaltersDuluth$147K
- Nicole SparksJohns Creek$121K
- Lethenia BakerThomaston$111K
- Renee AllenAtlanta$74K
- Matthew RalstenFayetteville$64K
- Murray FreedmanAugusta$48K
- Tosha Rogers-JonesAtlanta$46K
- Teresa ByrdMarietta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.